These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 24388408)
1. Pancreatoduodenectomy associated complications influence cancer recurrence and time interval to death. van der Gaag NA; Harmsen K; Eshuis WJ; Busch ORC; van Gulik TM; Gouma DJ Eur J Surg Oncol; 2014 May; 40(5):551-558. PubMed ID: 24388408 [TBL] [Abstract][Full Text] [Related]
2. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy. Serrano PE; Kim D; Kim PT; Greig PD; Moulton CA; Gallinger S; Wei AC; Cleary SP Am Surg; 2016 Dec; 82(12):1187-1195. PubMed ID: 28234183 [TBL] [Abstract][Full Text] [Related]
3. Postoperative complications influence prognosis and recurrence patterns in periampullary cancer. Cho JY; Han HS; Yoon YS; Hwang DW; Jung K; Kim YK World J Surg; 2013 Sep; 37(9):2234-41. PubMed ID: 23722466 [TBL] [Abstract][Full Text] [Related]
4. Survival after attempted surgical resection and intraoperative radiation therapy for pancreatic and periampullary adenocarcinoma. O'Connor JK; Sause WT; Hazard LJ; Belnap LP; Noyes RD Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1060-6. PubMed ID: 15978737 [TBL] [Abstract][Full Text] [Related]
5. Extended lymph node resection versus standard resection for pancreatic and periampullary adenocarcinoma. Staerkle RF; Vuille-Dit-Bille RN; Soll C; Troller R; Samra J; Puhan MA; Breitenstein S Cochrane Database Syst Rev; 2021 Jan; 1(1):CD011490. PubMed ID: 33471373 [TBL] [Abstract][Full Text] [Related]
6. Pancreaticoduodenectomy for periampullary cancer: does the tumour entity influence perioperative morbidity and long-term outcome? Wiltberger G; Krenzien F; Atanasov G; Hau HM; Schmelzle M; Bartels M; Benzing C Acta Chir Belg; 2018 Dec; 118(6):341-347. PubMed ID: 30203717 [TBL] [Abstract][Full Text] [Related]
7. Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer. Tol JA; Brosens LA; van Dieren S; van Gulik TM; Busch OR; Besselink MG; Gouma DJ Br J Surg; 2015 Feb; 102(3):237-45. PubMed ID: 25529117 [TBL] [Abstract][Full Text] [Related]
8. Recurrent disease after microscopically radical (R0) resection of periampullary adenocarcinoma in patients without adjuvant therapy. de Castro SM; Kuhlmann KF; van Heek NT; Busch OR; Offerhaus GJ; van Gulik TM; Obertop H; Gouma DJ J Gastrointest Surg; 2004 Nov; 8(7):775-84; discussion 784. PubMed ID: 15531230 [TBL] [Abstract][Full Text] [Related]
9. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial. Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348 [TBL] [Abstract][Full Text] [Related]
10. Pylorus preserving pancreaticoduodenectomy versus standard Whipple procedure: a prospective, randomized, multicenter analysis of 170 patients with pancreatic and periampullary tumors. Tran KT; Smeenk HG; van Eijck CH; Kazemier G; Hop WC; Greve JW; Terpstra OT; Zijlstra JA; Klinkert P; Jeekel H Ann Surg; 2004 Nov; 240(5):738-45. PubMed ID: 15492552 [TBL] [Abstract][Full Text] [Related]
11. [Risk factors of postoperative complications of pancreatoduodenectomy]. He KJ; Jiao XY; Yang XW; Hu YZ Ai Zheng; 2008 Jan; 27(1):75-7. PubMed ID: 18184469 [TBL] [Abstract][Full Text] [Related]
12. Is pancreatoduodenectomy justified for periampullary cancers with regional lymph node involvement? Shyr YM; Su CH; Lo SS; Wang HC; Lui WY Am Surg; 1995 Apr; 61(4):288-93. PubMed ID: 7893088 [TBL] [Abstract][Full Text] [Related]
13. Pancreaticoduodenectomy for periampullary adenocarcinoma. Andersen HB; Baden H; Brahe NE; Burcharth F J Am Coll Surg; 1994 Nov; 179(5):545-52. PubMed ID: 7952456 [TBL] [Abstract][Full Text] [Related]
14. Less morbidity after pancreaticoduodenectomy of patients with pancreatic cancer. Satoi S; Takai S; Matsui Y; Terakawa N; Iwaki R; Fukui J; Yanagimoto H; Takahashi K; Toyokawa H; Araki H; Kwon AH; Kamiyama Y Pancreas; 2006 Jul; 33(1):45-52. PubMed ID: 16804412 [TBL] [Abstract][Full Text] [Related]
15. [Analysis of prognosis-associated factors in pancreatic head and peri-ampullary cancer]. Roder JD; Siewert JR Chirurg; 1992 May; 63(5):410-5. PubMed ID: 1376655 [TBL] [Abstract][Full Text] [Related]
16. Palliative pancreaticoduodenectomy in pancreatic and periampullary adenocarcinomas. Wang SE; Shyr YM; Su CH; Chen TH; Wu CW Pancreas; 2012 Aug; 41(6):882-7. PubMed ID: 22286381 [TBL] [Abstract][Full Text] [Related]
17. Vascular resection in pancreaticoduodenectomy for periampullary cancers. A 10 year retrospective cohort study. Podda M; Thompson J; Kulli CTG; Tait IS Int J Surg; 2017 Mar; 39():37-44. PubMed ID: 28110027 [TBL] [Abstract][Full Text] [Related]
18. Predictors of long-term survival after pancreaticoduodenectomy for peri-ampullary adenocarcinoma: A retrospective study of 5-year survivors. El Nakeeb A; El Sorogy M; Ezzat H; Said R; El Dosoky M; Abd El Gawad M; Elsabagh AM; El Hanafy E Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):443-449. PubMed ID: 30126828 [TBL] [Abstract][Full Text] [Related]
19. [Pancreatic cancer. Analysis of 149 cases in our 17-year experience]. Carrabetta S; De Cian F; Mondini G; Bocchio MM; D'Ambra L; Spirito C; Lazzari I; Griffanti Bartoli F; Civalleri D G Chir; 1998; 19(6-7):265-70. PubMed ID: 9707831 [TBL] [Abstract][Full Text] [Related]
20. Reappraisal of a method of reconstruction after pancreatoduodenectomy. Lygidakis NJ; Jain S; Sacchi M; Vrachnos P Hepatogastroenterology; 2005; 52(64):1077-82. PubMed ID: 16001633 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]